Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Qiuyuan Shao"'
Publikováno v:
Renal Failure, Vol 46, Iss 2 (2024)
Background Hydroxychloroquine (HCQ) effectively improves lipid levels in patients with autoimmune diseases. This study aimed to examine the effect of HCQ on lipid profiles in patients with immunoglobulin A (IgA) nephropathy (IgAN) and determine wheth
Externí odkaz:
https://doaj.org/article/8312e14883dd4ca2ad08f88a27414267
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
BackgroundDiabetic kidney disease (DKD) remains the primary cause of end-stage renal disease (ESRD) globally, but treatment options are limited. Kunxian capsule (KXC) has been utilized for the treatment of autoimmune diseases and IgA nephropathy in C
Externí odkaz:
https://doaj.org/article/7af5be2b00604b4c9c196880b46fcda2
Publikováno v:
BMC Gastroenterology, Vol 20, Iss 1, Pp 1-4 (2020)
Abstract Background Intestinal perforation from peritoneal dialysis is rare, but the resulting complications are serious. Some patients do not necessarily have symptoms, and it can be difficult to differentiate their condition from PD-related (perito
Externí odkaz:
https://doaj.org/article/e8c79d87e6394e5ab6e4afd7b94929a0
Autor:
Jie Song, Jing Liu, Jia Luo, Qingyan Zhang, Yangyang Xia, Qiuyuan Shao, Cheng Sun, Chunming Jiang, Miao Zhang, Wei Zhu
Publikováno v:
Renal Failure, Vol 41, Iss 1, Pp 497-506 (2019)
Objectives: To improve the mouse model of relief for unilateral ureteral obstruction (RUUO) and explore the pathological process of renal fibrosis after the obstruction was relieved. Methods: C57BL/6 mice in model group were randomly divided into RUU
Externí odkaz:
https://doaj.org/article/c5aac55abac54fa0b41346f0850ba296
Publikováno v:
The Journal of Gene Medicine.
Macrophages regulates the transition of pericyte to peritoneal fibrosis through the GSDMD/IL-1β axis
Publikováno v:
International immunopharmacology. 101
Background End stage renal disease (ESRD) has caused public health problem with high prevalence worldwide. Peritoneum from peritoneal dialysis patients with ESRD can induce pathological changes of the peritoneum, including fibrosis. The trans-differe
Autor:
Cheng Sun, Miao Zhang, Wei Zhu, Yangyang Xia, Qiuyuan Shao, Chunming Jiang, Qingyan Zhang, Jing Liu, Jie Song, Jia Luo
Publikováno v:
Renal Failure
Renal Failure, Vol 41, Iss 1, Pp 497-506 (2019)
Renal Failure, Vol 41, Iss 1, Pp 497-506 (2019)
Objectives: To improve the mouse model of relief for unilateral ureteral obstruction (RUUO) and explore the pathological process of renal fibrosis after the obstruction was relieved. Methods: C57BL/6 mice in model group were randomly divided into RUU
Tanshinone IIA mitigates peritoneal fibrosis by inhibiting EMT via regulation of TGF-β/smad pathway.
Autor:
Qiuyuan Shao1, Chunming Jiang1, Cheng Sun1, Wei Zhu1, Dongwei Cao1, Yuan Feng1, Miao Zhang1 zhmiao19@126.com
Publikováno v:
Tropical Journal of Pharmaceutical Research. Dec2017, Vol. 16 Issue 12, p2857-2864. 8p.
Autor:
Peng-Fei Xu, Chunming Jiang, Jing Liu, Qiuyuan Shao, Cheng Sun, Nan Li, Qingyan Zhang, Yuan Feng
Publikováno v:
American journal of physiology. Renal physiology. 320(3)
Peritoneal dialysis (PD)-related peritoneal fibrosis (PF) is characterized by progressive extracellular matrix (ECM) accumulation in peritoneal mesothelial cells (PMCs) during long-term use of high glucose (HG)-based dialysates. Activation of the ren
Autor:
Chunming Jiang, Miao Zhang, Bo Jin, Jing Liu, Yangyang Xia, Yuan Feng, Peng-Fei Xu, Qiuyuan Shao, Cheng Sun, Qingyan Zhang, Wei Zhu
Publikováno v:
Exp Biol Med (Maywood)
Our previous study demonstrated that the mammalian target of rapamycin complex 1 (mTORC1) pathway is activated in peritoneal fibrosis under high glucose condition. This study aimed to investigate whether valsartan inhibits high glucose-induced perito
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83e40463a981a53e545c293c6736b8d0
https://europepmc.org/articles/PMC7427179/
https://europepmc.org/articles/PMC7427179/